Guardant360 CDx is the first FDA-approved comprehensive liquid biopsy with broad Medicare coverage.1,2
#1
liquid biopsy market share across tumor types3
15k
covered lives* and counting3
*Non-unique lives covered across Guardant360 Liquid CDx and Guardant360 Tissue, including overlap across tests and payers
ordering oncologist
user base3
Home Guardant Infinity™ for BioPharma Guardant360® CDx for BioPharma InfinityAI for BioPharma
>300m